entity

PROC

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PROC: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
13Hypotheses
0Analyses
1Outgoing
0Incoming
0Experiments
0Debates

No AI portrait yet

Outgoing (1)

TargetRelationTypeStr
Sepsisbiomarker_fordisease0.90

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (13)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
RBM45 Liquid-Liquid Phase Separation Dominance Hijacks RNA P 0.868 als -
MATR3 Nuclear Body Disruption Impairs RNA Processing Hubs an 0.801 als -
Endosomal trafficking defects are the common upstream lesion 0.730 neurodegeneration What determines the temporal sequence of
FUS Phase Separation Dominance in FTD-TDP: Aberrant Condensa 0.683 frontotemporal-dementia -
Dysregulated G3BP1 Signaling Impairs Local Translation in Ne 0.580 neurodegeneration How do disease-associated mutations in G
Cdk5/p25-PSD-95 Phosphorylation Disrupts Synaptic Scaffoldin 0.455 neurodegeneration Quantitative proteomics of the aging syn
Synaptic Vesicle Protein Phosphorylation Reprograms Release 0.455 neurodegeneration Quantitative proteomics of the aging syn
Dicer-Processed siRNA-Mediated Transcript Silencing 0.405 - How does the intron-retained RNA isoform
Cathepsin-Dependent Processing of Pro-Drug Enzymes 0.400 neurodegeneration How does controlled lysosomal membrane p
Temporal Processing Enhancement Hypothesis 0.000 - Unable to extract research questions - t
APP Processing Compartmentalization Therapeutics 0.000 - Lipid raft composition changes in synapt
Amyloid Precursor Protein Processing Modulation via Bacteria 0.000 - Gut-Brain Axis Therapeutics for Alzheime
Mitochondrial RNA Processing Enhancement 0.000 - RNA binding protein dysregulation across

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning PROC in their description or question text

Cdk5/p25-PSD-95 Phosphorylation Disrupts Synaptic Scaffolding and Shifts APP Pro

Score: 0.455 · neurodegeneration · 2026-04-27

Age-dependent p35-to-p25 cleavage activates Cdk5, which phosphorylates PSD-95 S561, disrupting AMPA/NMDA receptor anchor

Synaptic Vesicle Protein Phosphorylation Reprograms Release Probability and Inte

Score: 0.455 · neurodegeneration · 2026-04-27

Synaptic activity-dependent phosphorylation of synapsin-1 by CamKII and calcineurin dynamically regulates vesicle mobili

Dicer-Processed siRNA-Mediated Transcript Silencing

Score: 0.405 · unknown disease · 2026-04-26

Retained intronic sequences contain inverted repeat elements forming long dsRNA structures recognized by Dicer, which cl

Cathepsin-Dependent Processing of Pro-Drug Enzymes

Score: 0.400 · neurodegeneration · 2026-04-21

## Mechanistic Overview Cathepsin-Dependent Processing of Pro-Drug Enzymes starts from the claim that modulating CTSD, U

Temporal Processing Enhancement Hypothesis

Score: 0.000 · unknown disease · 2026-04-28

Targeted modulation of gamma-aminobutyric acid interneurons improves temporal sequencing abilities crucial for tracking

APP Processing Compartmentalization Therapeutics

Score: 0.000 · unknown disease · 2026-04-28

Selective targeting of secretase localization to shift APP processing from amyloidogenic to non-amyloidogenic pathways

Amyloid Precursor Protein Processing Modulation via Bacterial Enzyme Delivery

Score: 0.000 · unknown disease · 2026-04-28

Engineered gut bacteria producing α-secretase-like enzymes or β-secretase inhibitors can be delivered orally to influenc

Mitochondrial RNA Processing Enhancement

Score: 0.000 · unknown disease · 2026-04-28

Since RBP dysfunction affects mitochondrial RNA metabolism across these diseases, targeted enhancement of mitochondrial